awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38946563-1EB253AC-CAC6-47A3-8F60-265954D7E3D1
Q38946563-1EB253AC-CAC6-47A3-8F60-265954D7E3D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-1EB253AC-CAC6-47A3-8F60-265954D7E3D1
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies.
P2860
Q38946563-1EB253AC-CAC6-47A3-8F60-265954D7E3D1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38946563-1EB253AC-CAC6-47A3-8F60-265954D7E3D1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
62f7667d85977573e39ef0fd8abefcd8f2e0843c
P2860
Reversal of anticoagulants: an overview of current developments.